Salute e Benessere

Sterilization Services Market to Witness Robust Growth at 8.08% CAGR, Accounting…

Common sterilization methods encompass heat sterilization, such as autoclaving, chemical sterilization, radiation sterilization, and filtration sterilization. These methods effectively eliminate microorganisms, mitigating the risk of infections and ensuring the safety of products, equipment, and surfaces. Sterilization services utilize various techniques, such as steam autoclaves, where items are exposed to high-temperature, high-pressure steam. This approach proves highly effective in…

JELD-WEN Names Senior Leaders to Strengthen Customer Focus and Accelerate…

Matt Meier joins as EVP, Chief Digital and Information Officer Matt Meierjoins as EVP, Chief Digital and Information Officer CHARLOTTE, N.C.,Feb. 8, 2024/PRNewswire/ -- JELD-WEN Holding, Inc. (NYSE: JELD), a leading global manufacturer of building products, today announced three new leaders and a refreshed senior leadership team to accelerate the company's business performance. "To achieve JELD-WEN's full potential, we are focused on ensuring we have the right people and...

Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite…

Endocannabinoid system modulation has long been recognized as a promising avenue for appetite regulation. Through rigorous research and development efforts, Tetra Pharm Technologies has unlocked the potential of this biological system to address one of the most pressing health challenges of our time – excessive appetite and weight gain. TPT0701 was originally designed in 2022 for obese patients suffering from schizophrenia but will now move into the development stage as appetite...

Orexa Announces First Patient Dosed in Phase 2 Trial in Post-Operative Patients

"This is a major milestone for a company like Orexa to start its first clinical Phase 2 study," says Prof. Ard Peeters. He continues: "Finally we will be able to test our drug in patients. This first study is in a group where we can possibly prevent a so-called postoperative ileus. This is a serious complication, which affects up to 50% of patients in several patient groups and leads to patients being unable to eat and therefore recovering more slowly, resulting in prolonged…

XNK Therapeutics to present at Redeye Regenerative Medicine/Cell Therapy event

XNK's presentation will be followed by a short Q&A session. XNK's presentation will be followed by a short Q&A session. For more information, please contact: Johan Liwing, CEO, XNK TherapeuticsTel: +46 706 70 36 75 E-mail:johan.liwing@xnktherapeutics.com About XNK Therapeutics AB XNK Therapeutics is a clinical stage immunotherapy company focused on bringing new and more effective treatments to cancer patients. The company is at the forefront of autologous NK cell-based...

Orexo Interim Report Q4 2023, incl. Full Year Report

Important events after the end of the period Important events after the end of the period Financial outlook 2024 The financial outlook 2024 is based on a forward looking assumption of a USD/SEK exchange rate of 10.28 calculated as an average ofDecember 2023by the Riksbanken. Strong recovery in financial results and FDA initiated the review of OX124 CEO Comments in brief "I am pleased to report a Q4 result delivering a positive EBITDA and strong Zubsolv ®net...

Ultimovacs ASA: Invitation to fourth quarter 2023 results webcast presentation

Oslo, February 8, 2023: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, invites to a webcast presentation of its fourth quarter 2023 results on Wednesday, February 14, 2024.The presentation can be followed as a live webcast accessed through a link on www.ultimovacs.com at 13:00 CET on Wednesday, February 14, 2024, and is scheduled to conclude at 13:55 CET. The webcast presentation will be available on the...

Coway Announces Financial Results for Q4 and FY2023

Coway reported the following earnings: Coway reported the following earnings: In FY2023, strong domestic home appliance sales were primarily attributed to strong performance in core product categories like water purifiers, as well as the successful market expansion and sales growth of the BEREX brand. The factors collectively contributed to revenue ofKRW 2,373.5 billion(+4.2% YoY). In 2023, Coway's overseas subsidiaries achieved an annual revenue ofKRW 1,430.7 billion, marking a 2...

Pharming Group to participate in February investor conferences

Leiden, The Netherlands, February 8, 2024:Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's management will participate in the following investor conferences in the month of February: Oppenheimer 34 thAnnual Healthcare Life Sciences Virtual Conference, February 13-14, 2024Sijmen de Vries, Chief Executive Officer, will present on Tuesday, February 13 at 11:20 ET/17:20 CET. A live webcast and replay of the presentation will be...

A clearer vision for surgical robotics: CMR Surgical announces significant…

A clearer vision for surgical robotics: CMR Surgical announces significant update to Versius CMR Surgical launches vLimeLite * a new imaging technology to visualise ICG, the first product launch in a series of 2024 product releases as part of Versius Plus, a significant enhancement to the existing systemVersius Plus becomes the first CE marked surgical robot on the market to offer an integrated ICG system with multiple viewing modes and colour displays to visualise ICG, enhancing...

Nicox and Kowa Enter into Agreement for NCX 470 Development and…

Press ReleaseNicox and Kowa Enter into Agreement for NCX 470 Development and Commercialization in Japan €3 million upfront payment and a total of a further potential €27.5 million in milestonesTiered royalties on net sales of 7% to 12%Kowa to be responsible for all development and commercialization costs for NCX 470 in JapanUpfront payment extends Nicox cash runway to September 2024 February 8, 2024 – release at 7:30 am CETSophia Antipolis, France Nicox...

The Telerad Group's AI-powered RIS-PACS Takes Center Stage at Arab Health

The teleradiology market is projected to reach a valuation of US$ 40,873.30 million by 2033. This is possible only through embracing cutting-edge solutions to combat a global shortage of radiologists and an increasing demand for timely imaging solutions. Telerad Tech's RADSpa, the AI-enabled RIS-PACS workflow, is strategically designed to address such pressing challenges faced by the healthcare fraternity. With RADSpa's scalable and customizable AI-driven capability to optimize imaging data…

SEQUANA MEDICAL ANNOUNCES EUR 3.0 MILLION CONVERTIBLE FINANCING FROM MAJOR…

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 8 February 2024, 07:00 am CET FOCUS ON OBTAINING ALFAPUMP PMA APPROVAL REDUCES FORECAST CASH NEED FOR 2024 TO ADDITIONAL EUR 13.0 MILLION Momentum building towards planned alfapump...

Annual Report 2023: Strong execution across the company led to 13% organic…

2023 highlights GN delivered DKK 18.1 billion revenue with organic revenue growth of -1%, as a result of 13% organic revenue growth in GN Hearing and -8% organic revenue growth in GN AudioAdj. EBITA of DKK 1.8 billionNew capital plan from May 2023 provides solid foundation for strategy execution. Free cash flow excl. M&A of DKK 1,092 million which together with the other pillars of the capital plan drove a DKK 4 billion reduction in net interest-bearing debt. Adj. leverage ended...

Building on solid FY 2023 results, Ipsen anticipates four launches in 2024

Total-sales growth in FY 2023 of 6.7% at CER 1(3.4% as reported) included strong sales from the growth platforms 2and good contributions from the new medicines. A core operating margin of 32.0% (IFRS operating margin of 26.1%), based on further enrichment of the pipeline and accelerated R&D investment, mainly from recent acquisitionsFinancial guidance for 2024 3comprises total-sales growth 4greater than 6.0% at CER 1and a core operating margin 5around 30% of total sales,...

3DMakerpro Medical Debuts New Products at AEEDC Dubai 2024 Conference

"Digital dental care is the future of the dental industry, and 3D scanners have and will continue to play a crucial role in this evolution," said Yong Ding, CEO of 3DMakerpro. "In 2024, 3DMakerpro Medical is committed to expanding into international markets. We look forward to engaging with industry professionals at various global exhibitions to collectively advance the development of digital dental care." "Digital dental care is the future of the dental industry, and 3D…

ONWARD® MEDICAL ANNOUNCES PRESENTATION AT BIOCAPITAL EUROPE

CEO Dave Marver will present on the Company's use of brain-computer interface technology and progress toward planned commercialization of ARC-EX® later this year ONWARD Medical CEO Dave Marver will present and participate in 1:1 and group meetings with investors during the conference. During his engagements, he will also discuss the Company's leadership in innovative health solutions, including the use of ONWARD ARC-IM® Therapy paired with brain-computer interface (BCI) technology...

Global Mobile Pet Care Market Size to Surpass US$ 1,108.8 Million by 2030 |…

Global Mobile Pet Care Market Report Snapshot: Global Mobile Pet Care Market Report Snapshot: Key Market Takeaways: Market Trends: Two key trends are expected to shape the future of the Mobile Pet Care Market. Firstly, there is a rising demand for holistic and organic pet care products. Pet owners are increasingly prioritizing the use of natural ingredients and environmentally friendly products for their pets. This trend is driven by the growing awareness of the potential...

Bird Toys Market to Hit US$ 2.16 Billion By 2030: Report by CoherentMI

Bird Toys Market Report Snapshot: Bird Toys Market Report Snapshot: Key Market Takeaways: • Bird Toys market size is anticipated to witness aCAGR of 7.6%during the forecast period 2023-2030, owing to the increasing demand for eco-friendly toys and the growing trend of pet ownership and humanization. • On the basis of product type, the wooden toys segment is expected to hold a dominant position, owing to their eco-friendly nature and durability. Wooden toys offer a safe and...

Groupe Casino - Nombre de droits de vote et d'actions au 31-01-2024

CASINO, GUICHARD-PERRACHON Société anonyme au capital de 165 892 131,90 € Siège social : 1, Cours Antoine Guichard 42000 Saint-Etienne 554 501 171 R.C.S. Saint-Etienne Informations relatives au nombre total de droits de vote et d'actions composant le capital social au 31 janvier 2024(article 223-16 du Règlement Général de l'Autorité des Marchés Financiers)Nombre d'actions composant le capitalNombre total de droits de voteNombre total de droits de vote exerçables en...

SPINEWAY : 2023 annual results

Press release Ecully, February 7, 2024 – 6 p.m. SPINEWAY 2023 annual results2023 revenue of €10.5 million (+42%)Gross margin steady at 69%Net income heavily impacted by exceptional itemsImplementation in 2024 of a streamlining plan to achieve operating breakeven in the medium term 1 In thousands of eurosConsolidated accounts20232022Revenue10,5197,432 Cost of sales(3,309)(2,320) Gross margin7,2105,112%...

Medical Polymers Market Size to Grow USD 21320 Million by 2029 at a CAGR of 3.1%…

Claim Your Free Sample Now: https://reports.valuates.com/request/sample/QYRE-Auto-18T15867/Global_and_India_Medical_Polymers_Market Claim Your Free Sample Now:https://reports.valuates.com/request/sample/QYRE-Auto-18T15867/Global_and_India_Medical_Polymers_Market Major Factors Driving the Growth of Medical Polymers Market The market for medical polymers is expected to grow due to a number of factors, including the growing need for biocompatible materials in healthcare...

Cumulus Neuroscience Named GOOD DESIGN® Award Winner for Cutting-Edge EEG…

"To better identify and understand neuropsychiatric and neurodegenerative conditions, researchers and physicians need in-depth, reliable and repeatable data, which requires technology that is not only advanced in its abilities but is designed to meet the needs of patients," said Brian Murphy, PhD, Founder and Chief Scientific Officer, Cumulus Neuroscience. "Our comfortable and easy-to-use EEG headset has humanized the technology and experience for those living with often…

Abzena Launches LabZient™, an Analytical Platform to Expedite the Path to IND…

Dr Louise Duffy, Chief Technical Officer at Abzena said "By leveraging our extensive analytical expertise, laboratory methods, development data, and method qualification results, we've created a standardized, automated process that predicts how certain antibody molecules will behave, based on a structural assessment. This unique approach provides customers with critical data sooner, allowing them to make more informed decisions earlier in their development timeline that can ensure greater…

Altri Comunicati